Bio-Rad has launched a new web-based search tool to give researchers easier access to its validated siLentMer gene silencing product line, which offers up to twice the silencing longevity.
Bio-Rad Laboratories offer to buy BioSource International for
approximately $82 million (€64m) has been rejected again after
BioSource directors concluded that the proposed price was
significantly below BioSource's inherent value.
